- Stadtman Investigator, Clinical Genetics Branch
Dr. Shahinaz Gadalla earned her medical degree from Ain Shams University School of Medicine in Cairo, Egypt, and an M.S. and a Ph.D. in epidemiology from the University of Maryland, Baltimore. She joined the Clinical Genetics Branch within the NCI Division of Cancer Epidemiology and Genetics as a Cancer Prevention Fellow in 2008, and was promoted to a Staff Scientist in 2011. In 2014, she was appointed as an Earl Stadtman Tenure-Track Investigator. Dr. Gadalla’s research interests focus on the role of genetic factors in cancer etiology, as well as identifying genetic and environmental risk factors among individuals at high risk of developing cancer. She has received numerous awards for her work, including a Fellows’ Intramural Research Award and an NCI Director’s Intramural Innovation Award.
- (2020). Risk factors for inflammatory and non-inflammatory breast cancer in North Africa. BREAST CANCER RESEARCH AND TREATMENT. 184(2), 543-558.
- (2020). Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 26(8), 1459-1468.
- (2020). Survival following allogeneic transplant in patients with myelofibrosis. Blood Advances. 4(9), 1965-1973.
- (2020). Population Frequency of Fanconi Pathway Gene Variants and Their Association with Survival After Hematopoietic Cell Transplantation for Severe Aplastic Anemia. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 26(5), 817-822.